Insulet Lawsuit Alleges EOFlow Stole Diabetes Tech

The complaint says that EOFlow developed its EOPatch insulin delivery system with the help of former Insulet employees and Insulet’s contract manufacturer. Medtronic announced plans to acquire EOFlow in May, and US FDA clearance is on the horizon.

PS1810_Trade Secrets_298803143_1200.jpg

More from Legal & IP

More from Policy & Regulation